The restraint of older people is a serious and pressing issue for nursing practice and policy in the UK and overseas. Older people may be restrained in a number of ways. Physical restraint prevents individuals from moving around as they wish, or involves handling them; the environment may be configured to limit people's ability to move around freely, such as using electronic key pads or 'baffle' locks; there may be monitoring of people's movements via electronic surveillance, such as closed circuit television or tagging; and people may be chemically restrained by prescribed medication.
The focus of this article is chemical restraint. Mott et al (2005) say: 'Chemical restraint describes both deliberate and incidental use of pharmaceutical products to control behav-
Chemical restraint in nursing older people

Abstract
The inappropriate and over-prescribing of medication is an area of nursing fraught with legal and ethical considerations. It can lead to people being chemically restrained and must only be used in exceptional situations. Therapeutic alternatives should take precedent. This article reviews studies on chemical restraint that show high levels of neuroleptic drug prescribing, including pro re nata or 'when required' medication, in care settings for older people. Studies also demonstrate that chemical restraint tends to be used in busy and under-resourced settings. Reviews and audits of neuroleptic medication should be undertaken regularly to alert nurses to local trends and patterns.
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iour and/or restrict freedom of movement, but which is not required to treat a medically identified condition. These drugs may be purposively administered to sedate a patient as a means of convenience. Convenience is any action not in the patient's best interests to control or manage behaviour. ' The use of major tranquillisers (neuroleptics or antipsychoctics) and minor tranquillisers (anxiolytics or benzodiazepines) plays an important role in the clinical management of many conditions and illnesses that affect older people. The side effects of these drugs, which are generally referred to as neuroleptic medication, sedate people and can make them docile and compliant. Neuroleptic medication may be prescribed when required (also known by the Latin term pro re nata or PRN).
PRN medication should only be prescribed for defined medical conditions. Vague PRN instructions by prescribers leave the administration of these drugs up to individuals to decide and, make them open to abuse. Medicines should never be used to punish or control (Royal Pharmaceutical Society of Great Britain 2007) .
Because neuroleptic medication needs to be treated with caution, its over-use has been associated with a number of clinical problems. These include undermining physical and psychological wellbeing, which can impair rehabilitative progress (Mott et al 2005) ; increased risk of falls and associated injuries (Krauss et al 2005) ; and, for people living with dementia, these drugs can advance cognitive decline (Ballard et al 2005) .
It is important to place chemical restraint within a wider context of nursing practice, including issues concerning the administration of medicines and wider concerns of elder abuse. The National Care Standards Commission (NCSC) (2004) and the Commission for Social Care Inspection (CSCI) (2006) examined the management of medication in care services. Both studies found a series of problems, including: insecure storage of medicines wrong medication being administered poor recording and handling Older people's health and wellbeing can be put at risk from the poor management of medication. As both the NCSC (2004) and the CSCI (2006) report, the poor management of medication leaves, at worst, people at risk of abuse through the wilful maladministration of medicine.
A report on elder abuse by the house of Commons health committee (2004) noted that the over-prescription of medication was used to manage people and to make life easier for staff. As one witness reported: 'That concern [related to] the quantity, the combination, the lack of review and the lack of recording of medicines and to what is called "anticipatory prescribing", particularly of sedatives, which I think is a general problem, both in care homes and in perhaps wards caring for older people in hospital and that is where patients are given sedatives to ensure that they have a quiet night and therefore the staff have a quiet night. ' Following a short review of the policy context relevant to chemical restraint, this article reviews a number of relevant studies. These help to identify key patterns and trends in the use of chemical restraint and to explain why some older people are subject to chemical restraint. There are a number of practical implications of this legislation for nursing. First, the underlying causes for people's behaviour that require restraint need to be understood. Therapeutic interventions should be employed first. These non-restrictive interventions may include, for example, massage or music therapy when people are agitated or exhibiting challenging behaviour. Or when someone is exhibiting challenging behaviour de-escalation techniques (verbal communication to calm a person down) may be used (Madan 2005) .
Policy context
Second, the best interests of the individual are put at the centre of any decision to proceed with restraint. The older person should be able to exercise control and choice about the drugs they may be offered -and this includes ceasing their use. The wishes of carers and relatives should also be taken into account. Where people lack capacity, including when people have dementia, there are special procedures that need to be followed (Department for Constitutional Affairs 2007).
Third, restraints should only be used when there is serious risk of harm to the older person. The relative risk of using a restraint, versus not using a restraint, should be subject to a risk assessment. Decisions should be recorded and the least restrictive technique justified. Records on restraint should be subject to regular management review. Ballard C et al (2005) Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. 
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Clearly, neuroleptic drugs should be used with the utmost care, especially when they are prescribed PRN and when responsibility for administration may be left with nurses alone.
Chemical restraint: trends and patterns
Internationally, studies help to identify patterns in the use of chemical restraint. They may offer some understanding of why it is used, and the challenges nurses face when providing care. Findings from a range of studies are detailed in Table 1 .
Overall, studies indicate high levels of drugs associated with chemical restraint (McGrath and Jackson 1996 , Passmore et al 1996 , Oborne et al 2002 , Schweizer et al 2003 , hagen et al 2005 , Taylor et al 2006 . The studies selected for Table  1 illustrate that of the cases reviewed, between 9 per cent and 73 per cent of people were administered neuroleptic medication. Generally, only one third of these prescriptions were appropriate. Chemical restraint may be used routinely, because nurses have also reported sedating people to prevent them from interfering with medical treatments (feeding tubes, intravenous lines, catheters), from wandering and bothering others and to stop people from falling from chairs or out of bed (Kwasny et al 2006) .
Nursing staff also report the use of chemical restraint during busy periods, and sedating people has been reported to help manage workloads (Poole and Mott 2003) . Supporting this trend, lower nursing hours are associated with higher levels of psychoactive drug use (Schweizer et al 2003) .
Studies also raise particular concerns about the consistency of medication use. Taylor et al's (2006) study is particularly interesting in this respect. It found that older men are more likely to be prescribed drugs associated with chemical restraint than younger people and women. Within the context of existing research Taylor et al (2006) note these were unexpected findings and call for further research on the restraint of men in care homes.
Studies also indicate that people with high support needs, including those living in psychogeriatric care settings (Passmore et al 1996) , people with cognitive impairment and people who are more isolated and who receive fewer family visits (Voyer et al 2005) are more likely to be administered neuroleptic medication.
The studies selected in Table 1 There is an important read-across to be made between studies on chemical restraint and those on physical restraint. A systematised review of studies on physical restraint -defined as items that cannot be easily removed or are intended to prevent an individual's free bodily movements -in acute and residential settings gave a number of similar explanations to those identified in the chemical restraint studies. The review found physical restraint was justified by staff on the grounds of: ensuring the safety of people using services, including the prevention of falls, leaving a bed or chair (to maintain someone's posture and to provide a quiet time for people), going to a place that may be deemed risky or to prevent wandering. The review also found that restraint was used to prevent people from bothering others or taking items that do not belong to them preventing people harming themselves or others, especially when people were confused, agitated or exhibiting challenging behaviour facilitating treatment including preventing people disrupting their care, and interfering with medical devices being used on them maintaining the social and living environment benefiting staff, including to compensate for a lack of staff resources and to enable work schedules to be completed (Evans and Fitzgerald 2002) 
Discussion
Relatively little is known about the chemical restraint of older people in the UK, and studies tend to be concentrated in the United States, Australia, Canada and parts of mainland Europe. This is particularly striking as Bray et al (2004) Only 21% had a suitable diagnosis for the prescription of these drugs
Significant correlation between nursing hours and psychoactive prescriptions
Chemical restraint used to quieten down people who were agitated in order for work to be completed Nurses frustrated when small amounts of neuroleptic medication prescribed that take little effect Chemical restraint justified by nurses for the safety of people and nurses themselves 24% prescribed neuroleptic medication, 8%-72% of residents per care home 18% of residents prescribed neuroleptic medication appropriately 16 (10%) of people received neuroleptic medication. Nine patients had one medication, six had two medications and one patient had three medications. Restraint varied from one to nine days. Orders indicated the dose and frequency but not the time limits 28% of people received neuroleptic medication 1% of people received neuroleptic medication at home, 20% in elderly care units, 20% in residential care, 20% in nursing care and 58% in psychogeriatric care.
residents taking neuroleptic medication
Eight residents taking more than 1 type of neuroleptic medication
Prescriptions were appropriate in 27 residents 190 residents taking neuroleptic medication for inappropriate reasons including agitation, wandering, uncooperativeness and insomnia * Findings most relevant to chemical restraint are drawn out in this table.
Figures have been rounded more needs to be known about the use of chemical restraint. The explanations and common understandings for why restraint is necessary need to be challenged with evidence the alternatives to restraint need to be more fully understood, as do the challenges and opportunities involved in using these alternatives -from the perspectives both of older people and staff caring for those in often busy and under-resourced settings
The risk to people's physical and psychological wellbeing associated with chemical restraint means that the utmost care must be taken when administering medication. A decision to use a chemical restraint must be explicitly recognised and should not be taken lightly. In all cases the correct policies and procedures should be followed. If used inappropriately chemical restraint constitutes physical abuse and may be subject to disciplinary processes (Royal College of Nursing 2004).
In the literature one of the main reasons given for the use of restraint is to keep people safe. however, there are tensions. Irving's (2002) analysis of restraint suggests that discourses around restraint are typically set up via opposing views. These discourses indicate that if nurses do not want patients to be safe, then they must want them to come to harm. 'The other aspect of this discourse is that this powerfully and silently packages restraints as humane and caring, despite the obvious contradictions this represents. ' Restraint may therefore be justified as a means of keeping people safe. however, there is little evidence to support this (Black and haralambos 2005) . Studies demonstrate that there are also wider factors at work -such as sedating people because of staff shortages or sedating people who are confused or agitated rather than using often time-consuming and resource-intensive therapeutic approaches. These patterns of clinical practice do little to attend to the cause of the underlying problems -clinical or otherwise.
There is concern that the over-prescription and over-use of medication helps nurses to manage the care environment. In particular, the challenging behaviour some older people exhibit, which can make providing care difficult, may be made easier when people are sedated. There may also be issues concerning consent, especially with people who lack capacity such as those with dementia. The house of Commons health Committee (2004) noted that people with reduced capacity may be more at risk of over-prescribing.
Clearly, staff need support to ensure they follow best practice in this area, but there are wider prob- References (continued) lems to recognise in the management of medication (NCSC 2004 , CSCI 2006 . Staff may feel they do not have enough experience or knowledge in the use of medication, and may also feel unsupported with regard to best practice (Poole and Mott 2003) . PRN medications in particular place heavy responsibilities on nurses to decide when medications are to be given, if at all. Nurses need to be clear that PRN medications should have an upper-dose limit and time-scale, as well as frequency of administration and dose. Nurses should take steps to ensure the use of PRN medications is always carefully justified and documented.
Education and training programmes can improve the quality of care received by older people by enabling staff to deal with difficult situations in ways that do not require restraining interventions (Testad et al 2005) . These programmes need to be backed up in practice with good policies and protocols around medication management (NCSC 2004 , CSCI 2006 . Furthermore, before any intervention is used to restrain an older person, risk assessments need to be in place. While there may be a small number of situations in which chemical restraint is appropriate, it can only be seen as practice of the last resort and only undertaken after the right procedures have been carefully followed.
New mental capacity legislation in the UK reinforces the need for nursing policies and protocols to be sound and up-to-date. Nurses also need to be aware of the range of clinical, ethical and legal issues that surround the use of restraint. The challenge for nursing is to better equip staff to feel confident in caring for older people, especially in challenging circumstances, and in settings that are often busy and under-resourced. Gerontology. 24, 3, [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] 
Implications for practice
